Morse Asset Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11K Hold
175
﹤0.01% 389
2026
Q1
$599 Hold
175
﹤0.01% 382
2025
Q4
$495 Sell
175
-500
-74% -$2.58K ﹤0.01% 376
2025
Q3
$4.7K Sell
675
-900
-57% -$6.34K ﹤0.01% 300
2025
Q2
$9.32K Buy
1,575
+5
+0.3% +$29 ﹤0.01% 266
2025
Q1
$10K Sell
1,570
-5,599
-78% -$54K ﹤0.01% 245
2024
Q4
$85.2K Sell
7,169
-2,374
-25% -$40.5K 0.02% 186
2024
Q3
$264K Buy
+9,543
New +$239K 0.06% 159

Other funds holding ASPN

Morse Asset Management's ASPN Position: Q2 2026 in Review

Morse Asset Management held its Aspen Aerogels (ASPN) position steady in Q2 2026 at 175 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #389.

Morse Asset Management first reported a position in ASPN in Q3 2024 and has held it in 8 quarters since. The position peaked at $264K in Q3 2024. 180 funds tracked by Wall St. Rank hold ASPN as of Q2 2026.

  • Morse Asset Management held 175 shares of Aspen Aerogels worth $1.11K as of Q2 2026.
  • Morse Asset Management left its Aspen Aerogels share count unchanged in Q2 2026.
  • Aspen Aerogels made up ﹤0.01% of Morse Asset Management's portfolio in Q2 2026, its #389 holding.
  • Morse Asset Management first reported a position in Aspen Aerogels in Q3 2024 and has held it in 8 quarters since.
  • Morse Asset Management's Aspen Aerogels position peaked at $264K in Q3 2024.
  • 180 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2026.

Based on Morse Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.